TP53 and cancer: In NRAS mutant cancer cells, Kegg enrichment analysis identified several downregulated pathways, which included nucleotide oligomerization domain (NOD)-like receptor signaling pathways, p53 signaling pathway, NF-kappa B signaling pathway, sphingolipid pathways among others.